Menterra invests more than US$1m in Biosense Technologies

Menterra Venture Advisors, an impact investment fund that invests in early-stage social startups has announced a new round of investment in Biosense Technologies alongside its investment partner Artha Venture Challenge, impact investment initiative of the Singh Family Foundation. With the new round, Menterra and Artha have provided more than US$1m of direct equity funding and unlocked soft debt funding of more than US$2m through its network. The Maharashtra-based start-up provides quality, affordable and connected point-of-care diagnostics solutions for chronic diseases in India.

Biosense, started by a team of doctors and biomedical engineers, founded the company upon noticing the gaps in the provision of preventive care for chronic diseases, especially in non-metro cities and small towns of India. Initially, they started developing affordable medical devices that helped diagnose chronic problems from anaemia to diabetes and urine check. Today, they have six products and plan to scale up, in terms of R&D and distribution to other parts of the country.

Commenting on the investment, Mukesh Sharma, Head Menterra Venture Advisors says, “We have been associated with the team for over seven years now. First through incubation-fund platform at Villgro, and then with investment and intense post-investment support beyond risk capital. The teams’ …

To read more subscribe
Show More

Related Articles

Leave a Reply